Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J Williamson, Alex J Walker, Krishnan Bhaskaran, Seb Bacon, Chris Bates, Caroline E Morton, Helen J Curtis, Amir Mehrkar, David Evans, Peter Inglesby, Jonathan Cockburn, Helen I McDonald, Brian MacKenna, Laurie Tomlinson, Ian J Douglas, Christopher T Rentsch, Rohini Mathur, Angel Y S Wong, Richard Grieve, David Harrison, Harriet Forbes, Anna Schultze, Richard Croker, John Parry, Frank Hester, Sam Harper, Rafael Perera, Stephen J W Evans, Liam Smeeth, Ben Goldacre, Elizabeth J Williamson, Alex J Walker, Krishnan Bhaskaran, Seb Bacon, Chris Bates, Caroline E Morton, Helen J Curtis, Amir Mehrkar, David Evans, Peter Inglesby, Jonathan Cockburn, Helen I McDonald, Brian MacKenna, Laurie Tomlinson, Ian J Douglas, Christopher T Rentsch, Rohini Mathur, Angel Y S Wong, Richard Grieve, David Harrison, Harriet Forbes, Anna Schultze, Richard Croker, John Parry, Frank Hester, Sam Harper, Rafael Perera, Stephen J W Evans, Liam Smeeth, Ben Goldacre

Abstract

Coronavirus disease 2019 (COVID-19) has rapidly affected mortality worldwide1. There is unprecedented urgency to understand who is most at risk of severe outcomes, and this requires new approaches for the timely analysis of large datasets. Working on behalf of NHS England, we created OpenSAFELY-a secure health analytics platform that covers 40% of all patients in England and holds patient data within the existing data centre of a major vendor of primary care electronic health records. Here we used OpenSAFELY to examine factors associated with COVID-19-related death. Primary care records of 17,278,392 adults were pseudonymously linked to 10,926 COVID-19-related deaths. COVID-19-related death was associated with: being male (hazard ratio (HR) 1.59 (95% confidence interval 1.53-1.65)); greater age and deprivation (both with a strong gradient); diabetes; severe asthma; and various other medical conditions. Compared with people of white ethnicity, Black and South Asian people were at higher risk, even after adjustment for other factors (HR 1.48 (1.29-1.69) and 1.45 (1.32-1.58), respectively). We have quantified a range of clinical factors associated with COVID-19-related death in one of the largest cohort studies on this topic so far. More patient records are rapidly being added to OpenSAFELY, we will update and extend our results regularly.

Conflict of interest statement

Conflicts of Interest

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare the following: CB JP FH JC SH are employees of TPP. AM was interim Chief Medical Officer NHS Digital April-Sept 2019 (left NHS Digital end Jan 2020) and Digital Clinical Champion NHS England 2014-2015. All other authors have no competing interests.

Figures

Figure 1. Estimated log hazard ratio by…
Figure 1. Estimated log hazard ratio by age in years
Footnote: From the primary fully adjusted model containing a 4-knot cubic spline for age, and adjusted for all covariates listed in Table 2 except for ethnicity.
Figure 2. Illustration of data flows in…
Figure 2. Illustration of data flows in the OpenSAFELY platform
Figure 1. Flow diagram of cohort with…
Figure 1. Flow diagram of cohort with numbers excluded at different stages and identification of cases for the main endpoints.
Figure 2. Kaplan-Meier plots for COVID-19 related…
Figure 2. Kaplan-Meier plots for COVID-19 related death over time by age and sex
Figure 3. Estimated Hazard Ratios (shown on…
Figure 3. Estimated Hazard Ratios (shown on a log scale) for each potential risk factor from a multivariable Cox model
Footnote: Error bars represent limits of the 95% confidence interval for the hazard ratio. Obese class I: 30-34.9kg/m2, class II: 35-39.9kg/m2, class III: >=40kg/m2. OCS = oral corticosteroid. All HRs are adjusted for all other factors listed other than ethnicity. Ethnicity estimates are from a separate model among those with complete ethnicity data, and are fully adjusted for other covariates. Total n = 17,278,392 for non-ethnicity models, and 12,718,279 for ethnicity model.

References

    1. COVID-19 situation reports. .
    1. WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. 2020 .
    1. UK Government. Number of coronavirus (COVID-19) cases and risk in the UK. 2020 .
    1. NHS England. COVID-19 Daily Deaths. 2020
    1. Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24
    1. Docherty AB, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. medRxiv. 2020 doi: 10.1101/2020.04.23.20076042.
    1. Simonnet A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020 doi: 10.1002/oby.22831.
    1. Lighter J, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa415.
    1. Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review. Qeios; 2020.
    1. Guan W-J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 doi: 10.1056/NEJMoa2002032.
    1. Miyara M, et al. Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19. Qeios; 2020.
    1. Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity linked to incidence or outcomes of covid-19? BMJ. 2020;369:m1548.
    1. The Institute for Fiscal Studies. Are some ethnic groups more vulnerable to COVID-19 than others? 2020
    1. Public Health England. Disparities in the risk and outcomes from COVID-19. 2020 .
    1. ICNARC. COVID-19 Report. 2020 .
    1. ONS. Deaths registered weekly in England and Wales, provisional: week ending 17 April 2020. 2020 .
    1. Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020 doi: 10.1016/S2213-2600(20)30167-3.
    1. Boddington NL, et al. COVID-19 in Great Britain: epidemiological and clinical characteristics of the first few hundred (FF100) cases: a descriptive study. 2020 In preparation.
    1. Rentsch CT, et al. Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years. medRxiv. 2020 doi: 10.1101/2020.04.09.20059964.
    1. Farsalinos K, Barbouni A, Niaura R. Smoking, vaping and hospitalization for COVID-19. Qeios; 2020.
    1. MacKenna B, et al. Impact Of Electronic Health Record Interface Design On Unsafe Prescribing Of Ciclosporin, Tacrolimus and Diltiazem: A Cohort Study In English NHS Primary Care. JMIR. Preprints: Accepted for publication - in production .
    1. Opondo D, et al. Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record. PLoS One. 2015;10:e0129515.
    1. MacKenna B. Ghost branded generics: Why does the cost of generic atorvastatin vary? EBM DataLab. 2018
    1. Mathur R, et al. Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health. 2014;36:684–692.
    1. Public Health England. Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. 2020 .
    1. Marmot M, et al. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 2008;372:1661–1669.
    1. Coronavirus (COVID-19) cases in the UK. 2020
    1. GP Systems of Choice - NHS Digital. NHS Digital. .
    1. Future GP IT systems and services - NHS Digital. NHS Digital. .
    1. Clegg A, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45:353–360.
    1. Harcourt S, et al. Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data. Vaccine. 2018;36:565–571.
    1. Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf. 2005;14:443–451.
    1. Public Health England. Guidance on social distancing for everyone in the UK. . 2020 .
    1. Public Health England. UK immunisation schedule: the green book, chapter 11. . 2013 .
    1. Levey AS, et al. A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150:604.
    1. MacKenna B. What is the dm+d? The NHS Dictionary of Medicines and Devices. EBM DataLab. 2019
    1. Nissen F, et al. Validation of asthma recording in the Clinical Practice Research Datalink (CPRD) BMJ Open. 2017;7:e017474
    1. Morton C, Douglas I. OpenSAFELY Codelists: Asthma Diagnosis.
    1. MacKenna B, Douglas I. OpenSAFELY Codelists: Asthma Oral Prednisolone Medication. OpenSAFELY Codelists.
    1. Grint DJ, et al. Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis. BMJ Open. 2020;10:e034886
    1. McDonald H, Smeeth L. OpenSAFELY Codelists: Permanent Immunosuppresion. OpenSAFELY Codelists.
    1. Smeeth L, McDonald H. OpenSAFELY Codelists: Temporary Immunosuppresion. OpenSAFELY Codelists.
    1. Wong A, Schmidt SAJ, Langan S. Clinical Code List-Psoriasis-Read Codes. 2019
    1. Forbes H, et al. Clinical code list - SLE codes. 2014 doi: 10.17037/DATA.162.
    1. Pujades-Rodriguez M, et al. Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England. PLoS One. 2016;11:e0151245.
    1. OpenSAFELY Codelists: RA / SLE / Psoriasis.
    1. Strongman H, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet. 2019;394:1041–1054.
    1. OpenSAFELY Codelists: Cancer excluding lung and haematological.
    1. OpenSAFELY Codelists.
    1. Carpenter J, Kenward M. Multiple imputation and its application. Chichester: John Wiley & Sons; 2012.
    1. Pham TM, Carpenter JR, Morris TP, Wood AM, Petersen I. Population-calibrated multiple imputation for a binary/categorical covariate in categorical regression models. Stat Med. 2019;38:792–808.
    1. ONS. Population characteristics research tables. ONS; 2019. .
    1. BETA – Data Security Standards - NHS Digital. NHS Digital. .
    1. Data Security and Protection Toolkit - NHS Digital. NHS Digital. .
    1. ISB1523: Anonymisation Standard for Publishing Health and Social Care Data - NHS Digital. NHS Digital. .
    1. Secretary of State for Health and Social Care - UK Government. Coronavirus (COVID-19): notification to organisations to share information. 2020 .

Source: PubMed

3
Tilaa